Open AccessFasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects
Author(s) -
Salvatore Cortellino,
Alessandro Raveane,
Claudia Chiodoni,
Gloria Delfanti,
Federica Pisati,
V. Spagnolo,
Euplio Visco,
Giuseppe Fragale,
Federica Ferrante,
Serena Magni,
Fabio Iannelli,
Federica Zanardi,
Giulia Casorati,
Francesco Bertolini,
Paolo Dellabona,
Mario P. Colombo,
Claudio Tripodo,
Valter D. Longo
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.111256
Subject(s) - immunotherapy , immune system , medicine , tumor microenvironment , cancer immunotherapy , cancer , breast cancer , cancer research , triple negative breast cancer , adverse effect , immunology , oncology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom